EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb. 3, 2012--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its Annual
Meeting of Shareholders on Monday, February 6, at 4:00 p.m. CT.
Gary Maharaj, president and chief executive officer, Timothy Arens, vice
president of finance and interim chief financial officer, and Bob
Buhrmaster, chairman of the board, will provide an overview of the
outlook for the Company, and discuss certain financial results and
achievements for the fiscal year ended September 30, 2011 as well as
preliminary results from the first quarter of fiscal year 2012.
To access the webcast, go to the investor relations portion of the
Company's website at www.surmodics.com,
on the day of the Annual Meeting and click on the webcast icon. In
addition, the Annual Meeting audio and slide presentation will be
archived on the Company's website following the meeting.
About SurModics, Inc.
vision is to extend and improve the lives of patients through technology
innovation. The Company partners with the world’s foremost medical
device, pharmaceutical and life science companies to develop and
commercialize innovative products that result in improved diagnosis and
treatment for patients. Core offerings include: surface modification
coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro diagnostic
test kits and specialized surfaces for cell culture and microarrays.
SurModics is headquartered in Eden Prairie, Minnesota. For more
information about the Company, visit http://www.surmodics.com.
The content of SurModics’ website is not part of this release or part of
any filings the Company makes with the SEC.
Source: SurModics, Inc.
Timothy J. Arens, 952-500-7000
of Finance and interim Chief Financial Officer